Ursodeoxycholic acid for treatment of cholestasis in patients with hepatic amyloidosis
Background. Amyloidosis represents a group of different diseases characterized by extracellular accumulation of pathologic fibrillar proteins in various tissues and organs. Severe amyloid deposition in the liver parenchyma has extrahepatic involvement predominantly in the kidney or heart. We evaluat...
Main Authors: | Faust Dominik, Akoglu Bora, Ristić Gordana, Milović Vladan |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2009-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2009/0042-84500906482F.pdf |
Similar Items
-
A Case of Severe Cholestasis due to Hepatic AL Amyloidosis
by: Teresa Dias, et al.
Published: (2019-02-01) -
Ursodeoxycholic acid in neonatal sepsis-associated cholestasis
by: Rita Mey Rina, et al.
Published: (2014-08-01) -
Primary amyloidosis presenting intrahepatic cholestasis and fulminant hepatic failure
by: Ozturk Ates, et al.
Published: (2015-06-01) -
Intrahepatic cholestasis of pregnancy: Changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid
by: Dora Brites, PhD
Published: (2002-01-01) -
The peculiarities of morphological damages of the liver during obstructive cholestasis in clinic and experiment.
by: Gaydar Yu.A., et al.
Published: (2007-01-01)